Beam Therapeutics, Inc. (BEAM)
25.70
+1.10
(+4.47%)
USD |
NASDAQ |
Oct 09, 16:00
25.72
+0.02
(+0.08%)
Pre-Market: 20:00
Beam Therapeutics Cash from Operations (Quarterly) : -66.10M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -66.10M |
| March 31, 2026 | -128.51M |
| December 31, 2025 | -83.29M |
| September 30, 2025 | -81.48M |
| June 30, 2025 | -76.45M |
| March 31, 2025 | -103.88M |
| December 31, 2024 | -76.36M |
| September 30, 2024 | -88.12M |
| June 30, 2024 | -83.01M |
| March 31, 2024 | -99.75M |
| December 31, 2023 | 135.07M |
| September 30, 2023 | -89.78M |
| June 30, 2023 | -84.67M |
| March 31, 2023 | -109.82M |
| December 31, 2022 | -69.19M |
| September 30, 2022 | -74.50M |
| Date | Value |
|---|---|
| June 30, 2022 | -52.28M |
| March 31, 2022 | 218.49M |
| December 31, 2021 | 1.83M |
| September 30, 2021 | 3.007M |
| June 30, 2021 | -32.53M |
| March 31, 2021 | -38.58M |
| December 31, 2020 | -24.30M |
| September 30, 2020 | -21.21M |
| June 30, 2020 | -22.84M |
| March 31, 2020 | -27.39M |
| December 31, 2019 | -17.80M |
| September 30, 2019 | -16.99M |
| June 30, 2019 | -11.35M |
| March 31, 2019 | -25.86M |
| December 31, 2018 | -2.968M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Prime Medicine, Inc. | -41.05M |
| Intellia Therapeutics, Inc. | -83.11M |
| Twist Bioscience Corp. | 1.115M |
| Q32 Bio, Inc. | -3.075M |
| Sarepta Therapeutics, Inc. | 197.07M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -9.875M |
| Cash from Financing (Quarterly) | 7.523M |
| Free Cash Flow | -372.77M |
| Free Cash Flow Per Share (Quarterly) | -0.6567 |
| Free Cash Flow to Equity (Quarterly) | -65.05M |
| Free Cash Flow to Firm (Quarterly) | -68.51M |
| Free Cash Flow Yield | -13.98% |